[1]National Health and Family Planning Commission. Chinses colorectal cancer guideline (Verion 2017)［J］.Chin J Clinicians(Electronic Edition),2018 ,12(1):3-23.［国家卫生和计划生育委员会《中国结直肠癌诊疗规范（2017 年版）》专家组.中国结直肠癌诊疗规范（2017年版）［J］.中华临床医师杂志 (电子版)，2018,12(1):3-23.］
[2]Underhill ML，Germansky KA，Yurgelun MB，et al.Advances in hereditary colorectal and pancreatic cancers［J］.Clin Ther，2016，38(7)：1600-1621.
[3]M Katoh，M Unakami，M Hara，et al.Bone metastasis from colorectal cancer in autopsy cases［J］.J Gastroenterol 1995，30(5)：615-618.
[4]JA Bufill.Colorectal cancer：Evidence for distinct genetic categories based on proximal or distal tumor location［J］.Ann Intern Med，1990，113(10)：779-788.
[5]Wu JX，Li XH，Qi FZ.Diagnosis and treatment of bone metastases from colorectal carcinoma with a repot of 28 cases［J］.Chin J Bone Tumor and Bone Disease，2003，2(4)：215-216.［吴健雄，李兴华，祁付珍.结直肠骨转移28例诊治分析［J］.中国骨肿瘤骨病，2003，2（4）：215-216.］
[6]SC Nahas，CS Nahas，LA Bustamante-Lopez，et al.Prognostic factors of surgically-treated patients with cancer of the right colon：A ten years' experience of a single universitary institution［J］.Arq Bras Cir Dig，2015，28(1)：3-7.
［7 ］RA Meguid，MB Slidell，CL Wolfgang，et al.Is there a difference in survival between right-versus left-sided colon cancers［J］? Ann Surg Oncol，2008，15(9)：2388-2394.
[8]F Benedix，R Kube，F Meyer，et al.Comparison of 17，641 patients with right-and left-sided colon cancer：Differences in epidemiology，perioperative course，histology，and survival［J］.Dis Colon Rectum，2010，53(1)：57-64.
[9]I Laake，I Thune，R Selmer，et al.A prospective study of body mass index，weight change，and risk of cancer in the proximal and distal colon［J］.Cancer Epidemiol Biomarkers Prev，2010，19(6)：1511-1522.
[10]V Jurisic，S Radenkovic，G Konjevic，et al.The actual role of LDH as tumor marker，biochemical and clinical aspects［J］.Adv Exp Med Biol，2015，867：115-124.
[11]Xin Y，Han BH，Lou JT.Diagnostic significance of bone metabolites markers ICTP and BAP in bone metastasis of lung cancer［J］.Chinese Journal of Lung Cancer，2010，13(10)：947-953.［忻宇，韩宝惠，娄家陶.骨代谢标志物ICTP、BAP对肺癌骨转移的诊断意义［J］.中国肺癌杂志，2010，13(10)：947-953.］
[12]Ge YL，Zhang Z.The value of bone alkaline phosphatase in the diagnosis of bone tumors［J］.Chinese Journal of Medical Laboratory Science，2006，29(2)：136-139.［葛艳玲,张正.骨型碱性憐酸酶在骨肿瘤诊断中的价值［J］.中华检验医学杂志，2006，29（2）：136-139.］
［13 ］Hong RX，Lin QJ，Luo J，et al.Clinical featuers and prognosis in 104 colorectal cancer patients with bone metadtases［J］.Chin J Oncol，2013，35(10)：787-791.［洪若熙，林秋菊，罗健，等.104例结直肠癌骨转移患者的临床特征及预后［J］.中华肿瘤杂志，2013，35(10)：787-791.］
[14]JM Bae，JH Kim，NY Cho，et al.Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location［J］.Br J Cancer，2013，109(4)：1004-1012.
[15]M Gnant，M Balic，E Petru，et al.Treatment of bone metastases in patients with advanced breast cancer［J］.Breast Care(Basel)，2012，7(2)：92-98.
[16]T Yokota，T Ura，N Shibata，et al.BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer［J］.Br J Cancer，2011，104(5)：856-862.
[17]J Humphris，DK Chang，AV Biankin，et al.Inherited susceptibility to pancreatic cancer in the era of next-generation sequencing［J］.Gastroenterology，2015，148(3)：496-498.